For Immediate Release

Company name: DAIICHI SANKYO COMPANY, LIMITED
Representative: Joji Nakayama, Representative Director, President & CEO
(Code no.: 4568, First Section, Tokyo Stock Exchange)
Please address inquiries to Noriaki Ishida, Executive Officer,
Vice President, Corporate Communications Department
Telephone: +81-3-6225-1126
http://www.daiichisankyo.com

Daiichi Sankyo’s Japan Research Foundation for Clinical Pharmacology 8th Annual Clinical Pharmacology Research Award

Tokyo, Japan (June 25, 2015) – Daiichi Sankyo Company, Limited today announced that its affiliate, the Japan Research Foundation for Clinical Pharmacology* (headquarters, Tokyo; Director General, Kiyoshi Morita), has awarded its 8th “Japan Research Foundation for Clinical Pharmacology Research Award” to five young researchers.

 

Award recipients are selected from research papers submitted from projects funded with subsidies from the foundation, and innovative research projects with expectations for future development are eligible for the award.

 

The Foundation hopes that this award will motivate young clinical pharmacology researchers who are involved in the establishment of appropriate drug treatments and encourage future research results. The awards ceremony and presentation of research themes will be held on February 10, 2016.

 

*The mission of the Foundation is to promote clinical pharmacology and foster the development of clinical pharmacologists. The Foundation was established in 1975 and has worked on a variety of projects relating to clinical pharmacology, including promotion of research and overseas studies for Japanese researchers.

 

 

Recipients of the 8th Japan Research Foundation for Clinical Pharmacology Research Award

 

Recipient	Organization	Research theme
Haruhisa Inoue	Kyoto University	iPSC-based drug reprofiling for the treatment of neurodegenerative diseases in a new drug development
Yasue Kubota	Department of Nephro-Urology, Graduate School of Medical Sciences, Nagoya City University	Functional analysis of the SCF/Kit signaling pathway in overactive bladder and development of a new targeted therapy
Fuminori Sakurai	Department of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University	Development and clinical application of a detection system of circulating tumor cells using a conditionally replicating adenovirus
Naoki Sawada	Global COE Program and Department of Molecular Endocrinology and Metabolism, Tokyo Medical and Dental University (Present) Section of Cardiology, Department of Medicine, University of Chicago	Endothelial PGC-1α mediates vascular dysfunction in diabetes
Keiko Hosohata	Division of Clinical Pharmacology, Department of Pharmacology, School of Medicine, Jichi Medical University	Clinical evaluation of urinary vanin-1 for early detection of drug-induced kidney injury